During the past decade, Geisinger Medical Group conducted 80 clinical trials. In the 10-year time frame, 80 clinical trials started and 107 clinical trials were completed, i.e. on average, 133.8% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 58 clinical trials were completed. i.e. 386.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Geisinger Medical Group" #1 sponsor was "National Cancer Institute (NCI)" with 98 trials, followed by "Alliance for Clinical Trials in Oncology" with 27 trials sponsored, "SWOG Cancer Research Network" with 22 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 15 trials sponsored and "Gynecologic Oncology Group" with 15 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Geisinger Medical Group" #1 collaborator was "National Cancer Institute (NCI)" with 90 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator and "SWOG Cancer Research Network" with 8 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Geisinger Medical Group" are "Recurrent Breast Carcinoma" (8 trials), "Recurrent Ovarian Carcinoma" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials) and "HER2/Neu Negative" (6 trials). Many other conditions were trialed in "Geisinger Medical Group" in a lesser frequency.

Most popular intervention types in "Geisinger Medical Group" are "Drug" (158 trials), "Other" (128 trials), "Biological" (77 trials), "Procedure" (32 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (79 trials), "Quality-of-Life Assessment" (46 trials), "Paclitaxel" (24 trials), "Carboplatin" (23 trials) and "Questionnaire Administration" (21 trials). Other intervention names were less common.

The vast majority of trials in "Geisinger Medical Group" are 145 trials for "All" genders, 40 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Geisinger Medical Group". undefined are not yet recruiting, 17 are recruiting, 81 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 71 completed trials in Geisinger Medical Group, 2 suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Geisinger Medical Group, 8 "Phase 1" clinical trials were conducted, 87 "Phase 2" clinical trials and 94 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".